We are committed to leading the development of first-in-class, highly-selective, and potent small molecule inhibitors of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme highly expressed in select tissue (e.g., adipocytes, hepatocytes, muscle), where it plays a critical role in regulating energy metabolism and epigenetic pathways.​